Health Podcast Library

[Emergency Pod] Peptides - Part 1 with Sunita Mohanty of Ultralight

Apr 17, 2026
12:46

Episode Description

Christina Farr sits down with Sunita Mohanty, CEO and Co-founder of Ultralight, an AI-native operating system powering over 75 functional and longevity medicine clinics across the U.S. Sunita breaks down the regulatory whiplash driving a peptide black market, why the evidence base still hasn't caught up with patient demand, and why individual response varies so dramatically.

Join Christina for an upcoming webinar:

* 5/19 - What will AI do for employer healthcare and benefits with Garner Health - ⁠⁠https://streamyard.com/watch/sQfWpwRzMqWE⁠⁠

* 5/21 - The case for building an AI native electronic health record system - ⁠https://streamyard.com/watch/RCVSNheSPePs⁠

⁠⁠* 6/3 - Privacy, AI & the future of HIPAA with the former founding director of ONC - ⁠⁠https://streamyard.com/watch/bzW4sh8WAPyS⁠⁠

⁠* 6/23 - Not everyone can access the top 1% of physicians. Will AI change that? - ⁠⁠https://streamyard.com/watch/qY9td6fhiXK3⁠⁠


SPONSOR: Granola


Granola AI, The AI notepad for people in back-to-back meetings: https://granola.ai/liferswith code: LIFERS

Interested in sponsoring the show? lifers@a16zstudios.com


LINKS:
Ultralight: https://www.ultralighthealth.com/ 

Chrissy Farr on YouTube: https://www.youtube.com/@LiferswithChristinaFarr 
Chrissy Farr on Instagram: https://www.instagram.com/cfarr/ 
Subscribe to the Second Opinion Newsletter: https://secondopinion.media/ 
Chrissy’s Book: The Storyteller's Advantage: https://www.chrissyfarr.com/books 

 —
FOLLOW:
Sunita:
https://www.linkedin.com/in/sunita-mohanty/ 
https://x.com/sunitasmohanty 

Christina Farr:
https://www.linkedin.com/in/christinafarr/ 
https://x.com/chrissyfarr 



TIMESTAMPS:
(00:00) Welcome to Lifers
(00:22) Peptides everywhere
(01:00) Meet Sunita Mohanty
(01:58) Astrology to stacks
(02:54) Gray areas and risks
(05:16) Clinicians and compounding
(06:36) Sponsor break Granola
(07:15) Doctors self experimenting
(08:35) Why peptides skew male
(10:11) Prevention and policy
(11:35) Wrap up and next steps

 

Proudly Supported by

Supporting Podcasts